fbpx
EVENTS|NEWS|CONTACT|DONATE
Read Our Newsletter

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
antibody drug
Feb 28 2017

Ramucirumab Beneficial in Advanced Gastric/GEJ Cancers Regardless of Age

Regardless of age, patients with advanced gastric or gastroesophageal juncture (GEJ) cancer saw a survival benefit when treated with the monoclonal antibody ramucirumab. See more from the summary at the 2017 Gastrointestinal Cancers Symposium in San Francisco.

Read Source

Social Media

   

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Please join with us to fuel the next wave of progress.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.
Please join with us to fuel the next wave of progress. Support our 2024 Fundraising Campaign.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Together, we will defeat stomach cancer.

Together, we will defeat stomach cancer.

MORE INFODONATE
X